Application 218792
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | UPADACITINIB | UPADACITINIB | TABLET, EXTENDED RELEASE | 30MG | No | No |
| 003 | UPADACITINIB | UPADACITINIB | TABLET, EXTENDED RELEASE | 15MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rinvoq | UPADACITINIB | AbbVie Inc. | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | UPADACITINIB |